An Open-labelled Study to Characterise Fluciclovine (18F) Uptake Measured by positRon emissiON Tomography In Breast cancER
Phase of Trial: Phase II
Latest Information Update: 27 Dec 2018
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Breast cancer
- Focus Diagnostic use
- Acronyms FRONTIER
- 18 Dec 2018 Status changed from recruiting to completed.
- 22 Feb 2017 Status changed from not yet recruiting to recruiting.
- 03 Feb 2017 New trial record